Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 08, 2018
Crown Bioscience announced the expansion of its New Iberia, Louisiana research facilities to support novel capabilities including non-GLP clinical chemistry, biomarker services and proprietary early stage preclinical models.
read more
Wednesday, October 14, 2015
Crown Bioscience has entered an exclusive preclinical services alliance utilizing the world’s largest collection of naturally occurring diabetic translational models.
read more
Crown Bioscience has announced the appointment of Amar Thyagarajan, Ph.D., and Sandeep Sinha, Ph.D., to its team.
read more
Crown Bioscience has released another collection of life science products to its e-commerce platform.
read more
Wednesday, October 02, 2024
Crown Bioscience, a contract research organization (CRO) headquartered in San Diego, California in the United States, and a part of JSR Life Sciences and JSR Corporation, recently acquired by Japan Investment Corporation Capital Co., Ltd. , today ...
read more
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has expanded its San Diego facility to create CrownBio’s U.S. Center of Excellence for ...
read more
Tuesday, October 20, 2015
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of two respected industry veterans to its business ...
read more
Tuesday, January 09, 2018
CrownSyn is now available as an add-on feature to all two-drug combinatorial studies conducted by Crown Bioscience.
read more
Wednesday, April 19, 2017
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has launched an e-...
read more
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch...
read more
Thursday, September 22, 2016
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has published a further ...
read more
Wednesday, September 07, 2016
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance metabolic disease and oncology research, will be announcing the release of its new translational platforms for metabolic disease ...
read more
Crown Bioscience, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch of HuScreenTM, a new Translational Oncology service platform ...
read more
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, is announcing the launch ...
read more
Wednesday, March 30, 2016
Crown Bioscience Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more